Related Experiment Video
Updated: Jul 16, 2026
09:48
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
[Hemophilic pelvic pseudotumor].
Sandra Castro-Boix1, Jordi Pradell-Teigell, Ramón Boqué-Genovard
1Servicio de Cirugía General, Unidad de Cirugía Esofagogástrica, Hospital Vall d'Hebron, Barcelona, España. sandracastro73@hotmail.com
Cirugia Espanola
|February 20, 2007
Summary
Surgical excision is the definitive treatment for rare hemophilic pseudotumors. This case highlights successful pelvic bone pseudotumor resection using embolization and factor replacement for hemostasis in hemophilia patients.
Area of Science:
- Orthopedic Surgery
- Hematology
- Oncology
Background:
- Hemophilic pseudotumors are rare, occurring in 1-2% of hemophilia patients, primarily those with severe disease or inhibitors.
- Management options include conservative treatment, embolization, radiation, and surgical excision, with surgery being the only definitive cure.
Observation:
- A case of a hemophilic pseudotumor affecting the pelvic bone is presented.
- This complication is more prevalent in patients with severe hemophilia or those who have developed antibodies against factor VIII or IX.
Findings:
- The study details the successful surgical resection of a pelvic bone hemophilic pseudotumor.
- Treatment involved arterial embolization followed by surgical excision, with factor replacement utilized to ensure hemostasis.
Implications:
- This case demonstrates the feasibility and effectiveness of a combined embolization and surgical approach for managing hemophilic pseudotumors.
- Optimal management requires careful planning, including factor replacement, to mitigate bleeding risks during surgical intervention in hemophilic patients.